Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Change in Receivables (2016 - 2025)

Orthofix Medical's Change in Receivables history spans 15 years, with the latest figure at $4.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 56.46% year-over-year to $4.7 million, compared with a TTM value of $1.6 million through Dec 2025, down 83.38%, and an annual FY2025 reading of $1.6 million, down 83.38% over the prior year.
  • Change in Receivables for Q4 2025 was $4.7 million at Orthofix Medical, up from $2.0 million in the prior quarter.
  • The five-year high for Change in Receivables was $13.3 million in Q4 2023, with the low at -$5.4 million in Q1 2022.
  • Average Change in Receivables over 5 years is $1.8 million, with a median of -$78000.0 recorded in 2022.
  • Year-over-year, Change in Receivables soared 1143.63% in 2023 and then tumbled 2731.07% in 2025.
  • Tracing OFIX's Change in Receivables over 5 years: stood at $9.8 million in 2021, then plummeted by 30.6% to $6.8 million in 2022, then soared by 96.33% to $13.3 million in 2023, then fell by 18.73% to $10.8 million in 2024, then crashed by 56.46% to $4.7 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Change in Receivables are $4.7 million (Q4 2025), $2.0 million (Q3 2025), and -$2.7 million (Q2 2025).